Neferine attenuates doxorubicin-induced fibrosis and hypertrophy in H9c2 cells

Lohanathan, BP; Rathinasamy, B; Huang, CY; Viswanadha, VP

Viswanadha, VP (通讯作者)，Bharathiar Univ, Dept Biotechnol, Sch Biotechnol & Genet Engn, Coimbatore 641046, Tamil Nadu, India.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022; 36 (7):

Abstract

Doxorubicin (DOX), an anthracycline antineoplastic candidate is used to treat various malignancies. Around 41% of patients undergoing DOX treatment de......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索